Abstract:Background: Although synonymous single nucleotide variants (sSNVs) do not alter the protein sequences, they have been shown to play an important role in human disease. Distinguishing pathogenic sSNVs from neutral ones is challenging because pathogenic sSNVs tend to have low prevalence. Although many methods have been developed for predicting the functional impact of single nucleotide variants, only a few have been specifically designed for identifying pathogenic sSNVs. Results: In this work, we describe a computational model, IDSV (Identification of Deleterious Synonymous Variants), which uses random forest (RF) to detect deleterious sSNVs in human genomes. We systematically investigate a total of 74 multifaceted features across seven categories: splicing, conservation, codon usage, sequence, pre-mRNA folding energy, translation efficiency, and function regions annotation features. Then, to remove redundant and irrelevant features and improve the prediction performance, feature selection is employed using the sequential backward selection method. Based on the optimized 10 features, a RF classifier is developed to identify deleterious sSNVs. The results on benchmark datasets show that IDSV outperforms other state-of-the-art methods in identifying sSNVs that are pathogenic. Conclusions: We have developed an efficient feature-based prediction approach (IDSV) for deleterious sSNVs by using a wide variety of features. Among all the features, a compact and useful feature subset that has an important implication for identifying deleterious sSNVs is identified. Our results indicate that besides splicing and conservation features, a new translation efficiency feature is also an informative feature for identifying deleterious sSNVs. While the function regions annotation and sequence features are weakly informative, they may have the ability to discriminate deleterious sSNVs from benign ones when combined with other features. The data and source code are available on website http://bioinfo.ahu.edu.cn:8080/IDSV .

PhenoSV: interpretable phenotype-aware model for the prioritization of genes affected by structural variants

SVPath: an accurate pipeline for predicting the pathogenicity of human exon structural variants

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores

Quantify genetic variants’ regulatory potential via a hybrid sequence-oriented model

PhenoPro: a Novel Toolkit for Assisting in the Diagnosis of Mendelian Disease

Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease

Sequence-Based Prioritization of Nonsynonymous Single-Nucleotide Polymorphisms for the Study of Disease Mutations

De novo and somatic structural variant discovery with SVision-pro

Prioritization of Nonsynonymous Single Nucleotide Variants for Exome Sequencing Studies Via Integrative Learning on Multiple Genomic Data

FocalSV: target region-based structural variant assembly and refinement using single-molecule long read sequencing data

Clinical interpretation of CNVs with cross-species phenotype data

SUsPECT: a pipeline for variant effect prediction based on custom long-read transcriptomes for improved clinical variant annotation

Computational identification of deleterious synonymous variants in human genomes using a feature-based approach

PGG.SV: a whole-genome-sequencing-based structural variant resource and data analysis platform

GGTyper: genotyping complex structural variants using short-read sequencing data

Sawfish: Improving long-read structural variant discovery and genotyping with local haplotype modeling

Comprehensive Evaluation of Structural Variant Genotyping Methods Based on Long-Read Sequencing Data.

Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes

A Practical Guide for Structural Variation Detection in the Human Genome

A graph clustering algorithm for detection and genotyping of structural variants from long reads

Phen2Disease: a phenotype-driven model for disease and gene prioritization by bidirectional maximum matching semantic similarities.